Literature DB >> 8771288

Nutrition in cancer patients.

S Mercadante1.   

Abstract

Many factors can modify nutritional status in cancer patients, including cachexia, nausea and vomiting, decreased caloric intake or oncologic treatments capable of determining malabsorption. Cachexia is a complex disease characterized not only by a poor intake of nutrients or starvation, but also by metabolic derangement. Nausea and vomiting may limit the nutrient intake and are most often the consequences of oncologic treatments or opioid chronic therapy. Decreased caloric intake is considered to be one of the major causes of malnutrition, although the causes of anorexia remain unclear. Malabsorption is generally attributed to the consequences of oncologic treatments reducing the gastrointestinal absorption. Biochemical measurements and immunological tests may be not reliable indicators of nutritional status in cancer patients. Therefore, medical history, physical examination, estimates of daily oral intake, weight changes and an appropriate consideration of the nutritional requirements according to the stage of disease must still be assessed. The therapeutic approaches should be individualized and realistic. Whenever possible, oral nutrition is the method of choice, with due consideration for specific dietary needs. Nausea and anorexia can be reduced by different kinds of drugs. A careful decision based on good clinical judgement is necessary before deciding to start either enteral or parenteral nutrition, to avoid a useless, costly and difficult treatment. In choosing the route for administration of nutrients, availability of and access to a functioning gastrointestinal tract, compliance and comfort of the patient, gastrointestinal toxicity due to chemotherapy or radiotherapy fields, different costs, duration and place of treatment should be considered rather than the different capacity of parenteral versus enteral nutrition. However, postoperative periods after massive intestinal resection often require prolonged parenteral nutrition. The benefits of parenteral nutrition are not often demonstrable in patients with bowel obstruction. Different ethical aspects are presented. Flexibility in attempting to meet the nutrition needs of each patient is probably the most useful guide.

Entities:  

Mesh:

Year:  1996        PMID: 8771288     DOI: 10.1007/bf01769869

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  53 in total

1.  Home parenteral nutrition for patients with inoperable malignant bowel obstruction.

Authors:  D A August; D Thorn; R L Fisher; C M Welchek
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 May-Jun       Impact factor: 4.016

2.  Postoperative enteral vs parenteral nutrition. A randomized controlled trial.

Authors:  R H Bower; M A Talamini; H C Sax; F Hamilton; J E Fischer
Journal:  Arch Surg       Date:  1986-09

3.  Association between asthenia and nutritional status, lean body mass, anemia, psychological status, and tumor mass in patients with advanced breast cancer.

Authors:  E Bruera; C Brenneis; M Michaud; J Rafter; A Magnan; A Tennant; J Hanson; R N Macdonald
Journal:  J Pain Symptom Manage       Date:  1989-06       Impact factor: 3.612

4.  Metoclopramide infusion with a disposable portable pump.

Authors:  E Bruera; N MacDonald; C Brenneis; I Simpson; D LeGatt
Journal:  Ann Intern Med       Date:  1986-06       Impact factor: 25.391

5.  Preoperative parenteral feeding in patients with gastrointestinal carcinoma.

Authors:  J M Müller; U Brenner; C Dienst; H Pichlmaier
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

6.  A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

Authors:  E Bruera; K Macmillan; N Kuehn; J Hanson; R N MacDonald
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

Review 7.  Effects of artificial nutrition on the nutritional status of cancer patients.

Authors:  F Bozzetti
Journal:  JPEN J Parenter Enteral Nutr       Date:  1989 Jul-Aug       Impact factor: 4.016

8.  Preoperative outpatient nutritional support of patients with squamous cancer of the upper aerodigestive tract.

Authors:  M B Flynn; F F Leightty
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

9.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

10.  Carbohydrate metabolism in cancer cachexia.

Authors:  C P Holroyde; G A Reichard
Journal:  Cancer Treat Rep       Date:  1981
View more
  5 in total

1.  Nutrition in cancer patients: frustrating neglect and permanent challenge.

Authors:  G Delmore
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

2.  The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients.

Authors:  H Tong; E Isenring; P Yates
Journal:  Support Care Cancer       Date:  2008-06-13       Impact factor: 3.603

3.  Artificial nutrition and hydration in terminal cancer patients: the real and the ideal.

Authors:  Do Youn Oh; Jee Hyun Kim; Se Hoon Lee; Dong Wan Kim; Seock Ah Im; Tae You Kim; Dae Seog Heo; Yung Jue Bang; Noe Kyeong Kim
Journal:  Support Care Cancer       Date:  2006-11-11       Impact factor: 3.359

4.  Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis.

Authors:  Claire Barber; Roy Powell; Annie Ellis; Julie Hewett
Journal:  Support Care Cancer       Date:  2006-11-28       Impact factor: 3.359

5.  Malnutrition and cachexia among cancer out-patients in Nairobi, Kenya.

Authors:  L U Kaduka; Z N Bukania; Y Opanga; R Mutisya; A Korir; V Thuita; C Nyongesa; M Mwangi; C F L Mbakaya; E Muniu
Journal:  J Nutr Sci       Date:  2017-12-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.